![](https://webarchive.library.unt.edu/eot2008/20081101034709im_/http://www.nci.nih.gov/images/spacer.gif) |
¿Preguntas sobre el cáncer?
![](https://webarchive.library.unt.edu/eot2008/20081101034709im_/http://www.nci.nih.gov/images/spacer.gif)
|
1-800-422-6237
(1-800-4-CANCER)
|
![](https://webarchive.library.unt.edu/eot2008/20081101034709im_/http://www.nci.nih.gov/images/spacer.gif)
|
Llame de lunes a viernes de 9:00 a.m. a 4:30 p.m., hora local en Estados Unidos y sus territorios. |
|
![](https://webarchive.library.unt.edu/eot2008/20081101034709im_/http://www.nci.nih.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081101034709im_/http://www.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081101034709im_/http://www.nci.nih.gov/images/spacer.gif)
| Carcinoma lobular in situ. Afección en la que se encuentran células anormales en los lóbulos de la mama. No es frecuente que el CLIS se convierta en carcinoma lobular invasor; sin embargo, tenerlo en una mama aumenta el riesgo de padecer de cáncer de mama (seno) en cualquiera de las mamas. También se llama carcinoma lobular in situ. |
![](https://webarchive.library.unt.edu/eot2008/20081101034709im_/http://www.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081101034709im_/http://www.nci.nih.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081101034709im_/http://www.nci.nih.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20081101034709im_/http://www.nci.nih.gov/images/spacer.gif) |